ONL Therapeutics' Series A Round

ONL Therapeutics raised a round of funding on May 17, 2017.

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors. Existing therapies have significant limitations and none address the initial ne…

Articles about ONL Therapeutics' Series A Round: